Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?
Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh
V Keshavdev - December 10, 2020
A Growing Appetite
Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market
Krishna Gopalan - November 28, 2017
At Home With Art
Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art
Krishna Gopalan - August 19, 2017
Under The Weather - Part 2
Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home
Krishna Gopalan - June 05, 2017
Under The Weather- Part 1
The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home
Krishna Gopalan - May 20, 2017
Managing Growth 2017- Part 2
Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal
March 17, 2017
Managing Growth 2017- Part 1
CEOs from diverse sectors on what's in store for 2017
March 17, 2017
Growth eclipse
After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?
Krishna Gopalan - January 22, 2016
Cash-rich picks in the current market
Looking for cash bargains? Here is a first cut list
Jitendra Kumar Gupta - August 26, 2015
Dilip Shanghvi
The Sun Pharma founder is a man of few words and the perfect dose of calm and strength
Krishna Gopalan - July 02, 2015
